| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Abbott Laboratories (NYSE:ABT) will release earnings results for the third quarter, before the opening bell on Wednesday, Oct. 15.
Analysts expect the North Chicago, Illinois-based company to report quarterly earnings at $1.30 per share, up from $1.21 per share in the year-ago period. Abbott Laboratories projects quarterly revenue of $11.4 billion, compared to $10.63 billion a year earlier, according to data from Benzinga Pro.
On Sept. 19, the company's board of directors declared a quarterly common dividend of 59 cents per share.
Abbott Laboratories shares fell 0.6% to close at $132.57 on Friday.
Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.
Considering buying ABT stock? Here’s what analysts think:

Read This Next:
Photo via Shutterstock
Posted In: ABT